FrancophonIA/ELRC3.0 huggingface dataset:
English: • The usual dose is 11 or 15 MBq per kg body weight, depending on your blood platelet count.
Croatian: • Uobičajena doza iznosi 11 ili 15 MBq po kilogramu tjelesne težine, ovisno o broju trombocita u krvi.
English: Total Body
Croatian: Cijelo tijelo
English: Consolidation therapy:
Croatian: Konsolidacijska terapija:
English: If you have been treated with other proteins (especially mouse-derived) before Zevalin treatment, you may be more likely to have an allergic reaction.
Croatian: Ako ste liječeni drugim proteinima prije liječenja Zevalinom (osobito onima dobivenim iz miševa), postoji veća vjerojatnost da ćete imati alergijsku reakciju.
English: Duration of response: interval from the onset of response to disease progression.
Croatian: Trajanje odgovora: razdoblje od početka odgovora do napredovanja bolesti.
English: For patient subgroups in PR or CR after induction, median PFS was 6.3 vs 29.7 months (p<0.0001; HR 0.304) and 29.9 vs 54.6 months (p=0.015; HR 0.613), respectively.
Croatian: Za podskupine bolesnika s PR-om ili CR-om nakon indukcijske terapije, medijan PFS-a bio je 6,3 nasuprot 29,7 mjeseci (p < 0,0001; HR 0,304), odnosno 29,9 nasuprot 54,6 mjeseci (p = 0,015, HR 0,613).
English: Contaminated materials must be disposed of as radioactive waste by the authorised route.
Croatian: Kontaminirani materijali moraju se zbrinuti kao radioaktivni materijal putem ovlaštenih ustanova.
English: Using a 10-ml syringe with a large bore needle (18-20 G), draw formulation buffer that will result in a combined total volume of 10 ml.
Croatian: Pomoću štrcaljke volumena 10 ml s iglom velikog promjera (18-20 G) izvucite toliko pufera za pripremu formulacije da postignete ukupni kombinirani volumen od 10 ml.
English: For instructions on extemporary preparation of the medicinal product before administration,see section 12.
Croatian: Za uputu o pripravi lijeka prije primjene vidjeti dio 12.
English: The isotope yttrium-90 is a pure β-emitter and has a mean path length of about 5 mm.
Croatian: Izotop itrij-90 čisti je β-emiter i ima prosječnu duljinu putanje od 5 mm.
English: Adverse reactions listed below are classified according to frequency and System Organ Class (MedDRA).
Croatian: Nuspojave navedene u nastavku razvrstane su u skladu s učestalošću i klasifikacijom organskih sustava (MedDRA).
English: Total Alpha impurities
Croatian: Ukupne alfa-nečistoće
English: During B-cell maturation, CD20 is first expressed in the midstage of B-lymphoblast (pre-B-cell), and is lost during the final stage of B-cell maturation to plasma cells.
Croatian: Tijekom sazrijevanja B-stanica CD20 najprije se izražava u srednjoj fazi B-limfoblasta (prekursora B-stanica), a gubi se u završnoj fazi sazrijevanja B-stanica u plazma stanice.
English: There is a potential risk that ionizing radiation by Zevalin could harm your ovaries and testicles.
Croatian: Postoji potencijalni rizik da bi ionizirajuće zračenje Zevalina moglo naškoditi jajnicima ili testisima.
English: The linker chelate tiuxetan forms a stable complex with the radioisotopes yttrium-90 and indium-111 and only negligible degradation due to radiolysis is expected.
Croatian: Vezni kelat tiuksetan tvori stabilan kompleks s radioizotopima itrij-90 i indij-111 te se očekuje samo zanemarivo raspadanje zbog radiolize.
English: Zevalin is not recommended for use in children below age 18 since safety and efficacy have not been established.
Croatian: Primjena Zevalina ne preporučuje se kod djece mlađe od 18 godina jer sigurnost i djelotvornost lijeka nisu utvrđene.
English: Y]-Zevalin activity per body weight (11 MBq/kg) was used.
Croatian: Y]-Zevalina po tjelesnoj težini (11 MBq/kg).
English: The dose of Zevalin depends on your body weight, blood platelet counts and what Zevalin is being used for (indication).
Croatian: Doza Zevalina ovisi o Vašoj tjelesnoj težini, broju trombocita u krvi i namjeni primjene Zevalina (indikaciji).
English: Limited data in elderly patients (aged 65 years or over) are available.
Croatian: Za bolesnike starije dobi (dobi od 65 ili više godina) dostupni su ograničeni podaci.
English: If your doctor plans to treat you with some other antibody after treatment with Zevalin, you will need to be tested for special antibodies.
Croatian: Ako Vas liječnik nakon liječenja Zevalinom namjerava liječiti nekim drugim protutijelom, morat ćete se testirati na posebna protutijela.
English: The amount of radiation that your body will be exposed to due to Zevalin is smaller than with radiotherapy.
Croatian: Količina zračenja kojoj se tijelo izlaže zbog Zevalina manja je od one kojoj se izlaže tijekom radioterapije.
English: Spot one strip at a time and run three ITLC strips.
Croatian: Jednu po jednu, nakapajte tri trakice i provedite ITLC.
English: For consolidation therapy in patients with follicular lymphoma • The usual dose is 15 MBq/kg body weight.
Croatian: Za konsolidacijsku terapiju u bolesnika s folikularnim limfomom • Uobičajena doza iznosi 15 MBq/kg tjelesne težine.
English: Since IgGs are known to cross the placenta, and because of the significant risk associated with radiation, Zevalin is contraindicated during pregnancy (see section 4.3).
Croatian: Budući da je poznato da IgG protutijela prolaze posteljicu te da je sa zračenjem povezan značajan rizik, Zevalin je kontraindiciran tijekom trudnoće (vidjeti dio 4.3).
English: The product of radioactive decay is stable zirconium-90.
Croatian: Proizvod radioaktivnog raspada stabilni je cirkonij-90.
English: Patients whose response status changed after Zevalin from PR to CR showed a significantly longer median progression free survival time (986 days) compared to those patients who remained in PR (median progression free survival time of 460 days, p=0.0004).
Croatian: Bolesnici čiji se odgovor nakon Zevalina promijenio iz PR-a u CR pokazali su značajno duži medijan PFS-a (986 dana) u usporedbi s onima koji su ostali u PR (medijan PFS-a 460 dana, p = 0,0004).
English: 10 ml of formulation buffer
Croatian: 10 ml pufera za pripremu formulacije
English: • infection: fever, chills
Croatian: • infekcija: vrućica, zimica
English: The use of Zevalin is associated with an increased risk of secondary malignancies, including acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), (see also section 4.8).
Croatian: Primjena Zevalina povezana je s povećanim rizikom od sekundarnih zloćudnih bolesti uključujući akutnu mijeloičnu leukemiju (AML) i mijelodisplastični sindrom (MDS) (vidjeti također dio 4.8).
English: In particular, your doctor will need to interrupt treatment with growth factors such as filgrastim for a period of three weeks before giving you Zevalin to two weeks after Zevalin treatment.
Croatian: Konkretno, liječnik će morati prekinuti liječenje čimbenicima rasta, kao što je filgrastim, u razdoblju od tri tjedna prije početka primjene Zevalina do dva tjedna nakon liječenja Zevalinom.
English: In case of hypersensitivity reactions, Zevalin infusion must be stopped immediately.
Croatian: U slučaju reakcija preosjetljivosti potrebno je odmah prekinuti infuziju Zevalina.
English: In]-radiolabelled Zevalin, blood sampling, and the MIRDOSE3 software program.
Croatian: In] gama-emiterom, uzimanja uzoraka krvi i softverskog programa MIRDOSE3.
English: After treatment your doctor will perform regular blood tests to check your platelet and white cell counts.
Croatian: Nakon terapije liječnik će provoditi redovite krvne pretrage radi provjere broja trombocita i leukocita.
English: In case of a potential severe infusion reaction treatment must be stopped immediately.
Croatian: U slučaju potencijalno teške infuzijske reakcije potrebno je odmah prekinuti liječenje.
English: • Mucocutaneous reactions, including Stevens-Johnson Syndrome
Croatian: • reakcije na koži ili sluznici, uključujući Stevens-Johnsonov sindrom
English: If you are given Zevalin less than 4 months after chemotherapy containing the active substance fludarabine, you may have a higher risk of having a reduced number of blood cells.
Croatian: Ako Zevalin primite unutar 4 mjeseca nakon kemoterapije koja je sadržavala fludarabin, izloženi ste većem riziku od smanjenja broja krvnih stanica.
English: Infusions must be administered under the close supervision of an experienced physician with full resuscitation facilities immediately available (for radiopharmaceutical precautions see also sections ‘4.2 and 12').
Croatian: Infuzije je potrebno davati pod strogim nadzorom iskusnog liječnika uz trenutno dostupnu opremu za reanimaciju (mjere opreza vezane uz radiofarmaceutike potražite u dijelovima 4.2 i 12).
English: Place each half into separate scintillation vials to which 5 ml LSC cocktail must be added (e.g. Ultima Gold, catalog No. 6013329, Packard Instruments, USA or equivalent).
Croatian: Polovice stavite u zasebne scintilacijske bočice u koje se mora dodati 5 ml LCS koktela (npr. Ultima Gold, kataloški br. 6013329, koji proizvodi Packard Instruments, SAD, ili ekvivalentan).
English: • severe mucous membrane reactions, which may occur days or months after Zevalin and/or rituximab administration.
Croatian: • teške reakcije na sluznici, koje se mogu dogoditi u razdoblju od nekoliko dana do nekoliko mjeseci nakon primjene Zevalina i/ili rituksimaba.
English: Objective, durable clinical responses were observed [67% ORR (95% CI: 48-85%), 11.8 months median DR (range: 4-17 months)] and resulted in a greater incidence of haematologic toxicity (see 4.8) than in Studies 1 and 2.
Croatian: Primijećeni su objektivni, dugi klinički odgovori [ORR od 67 % (95% CI: 48%-85 %), medijan DR-a 11,8 mjeseci (raspon: 4-17 mjeseci)], s posljedičnom većom incidencijom hematološke toksičnosti (vidjeti dio 4.8) nego u ispitivanjima 1 i 2.
English: Y] was 28 h.
Croatian: Y] u serumu iznosio je 28 sati.
English: Induction therapies included CVP n=106, CHOP (-like) n=188, fludarabine combinations n=22, chlorambucil n=39 and rituximab-chemotherapy combinations n=59.
Croatian: Indukcijski protokoli uključivali su CVP (n = 106), CHOP (i slične, n = 188), kombinacije fludarabina (n = 22), klorambucil (n = 39) te kombinacije kemoterapije s rituksimabom (n = 59).
English: In most patients, administration of Zevalin (after pretreatment with rituximab) results in severe and prolonged cytopenia which is generally reversible (see section 4.8).
Croatian: U većine bolesnika primjena Zevalina (nakon prethodnog liječenja rituksimabom) dovodi do teške i dugotrajne citopenije koja je većinom reverzibilna (vidjeti dio 4.8).
English: Treatment consists of discontinuation of Zevalin and supportive therapy, which may include growth factors.
Croatian: Liječenje se sastoji od prekida primjene Zevalina i potporne terapije, koja može uključivati čimbenike rasta.
English: Y]-radiolabelled Zevalin must only be received, handled and administered by qualified personnel and must be prepared in accordance with both radiation safety and pharmaceutical quality requirements (for more details see also sections 4.4, 6.6 and 12).
Croatian: Y] smije zaprimati, koristiti i primjenjivati samo kvalificirano osoblje, a mora se pripremati u skladu sa zahtjevima propisa o zaštiti od radioaktivnosti i farmaceutskoj kakvoći (za dodatne pojedinosti vidjeti dijelove 4.4, 6.6 i 12).
English: - Hypersensitivity to ibritumomab tiuxetan, to yttrium chloride, or to any of the excipients listed in section 6.1.
Croatian: - Preosjetljivost na ibritumomab tiuksetan, itrijev klorid ili na neku od pomoćnih tvari navedenih u dijelu 6.1.
English: Incubate the yttrium-90 chloride/acetate/ibritumomab tiuxetan solution at room temperature for five minutes.
Croatian: Inkubirajte otopinu itrij-90 klorida/acetata/ibritumomab tiuksetana na sobnoj temperaturi pet minuta.
English: Fatal outcomes have been reported for each of the following serious adverse drug reactions.
Croatian: Za svaku od sljedećih ozbiljnih nuspojava lijeka prijavljeni su smrtni ishodi.
English: • Contraception
Croatian: • Kontracepcija
English: Clean the rubber stopper of all cold kit vials and the yttrium-90 chloride vial with a suitable alcohol swab and allow to air dry.
Croatian: Očistite gumene čepove svih bočica iz hladnog seta i bočice itrij-90 klorida pomoću odgovarajuće vate natopljene alkoholom pa pustite da se osuše.
English: The conjugated antibody has an apparent affinity constant for the CD20 antigen of approximately 17 nM.
Croatian: Konjugirano protutijelo ima prividnu konstantu afiniteta za antigen CD20 od približno 17 nM.
English: Myelodysplastic syndrome (MDS)/ acute myeloid leukaemia (AML) has been reported in eleven out of 211 patients with relapsed or refractory NHL assigned to treatment with Zevalin in four studies.
Croatian: Mijelodisplastični sindrom (MDS) / akutna mijeloična leukemija (AML) zabilježeni su u 11 od 211 bolesnika s recidivirajućim ili refraktornim NHL-om koji su primali Zevalin u četiri ispitivanja.
English: Patients who had received murine-derived proteins before Zevalin treatment must be tested for human anti-murine antibodies (HAMA).
Croatian: Bolesnike koji su prije liječenja Zevalinom primali proteine dobivene iz mišjih tkiva mora se testirati na humana antimišja protutijela (HAMA).
English: • Risk Management Plan (RMP) The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan, as agreed in version 1.1 of the Risk Management Plan (RMP) presented in Module 1.8.2 of the Marketing Authorisation Application and any agreed subsequent updates of the RMP.
Croatian: Nositelj odobrenja se obvezuje provoditi ispitivanja i dodatne aktivnosti predviđene Farmakovigilancijskim planom, kako je dogovoreno verzijom 1.1 Plana upravljanja rizicima (RMP) prikazanoj u Modulu 1.8.2.
English: decreased counts of all blood cells (pancytopenia)*; decreased number of lymphocytes
Croatian: smanjenje broja svih krvnih stanica (pancitopenija)*, smanjenje broja limfocita
English: The safety and efficacy of immunization with any vaccine, particularly live viral vaccines, following therapy with Zevalin have not been studied (see also section ‘Special warnings and precautions for use').
Croatian: Sigurnost i djelotvornost imunizacije nijednim cjepivom, osobito cjepivima sa živim virusima, nakon terapije Zevalinom nisu ispitane (vidjeti također dio "Posebna upozorenja i mjere opreza pri uporabi").
English: • Secondary malignancies
Croatian: • Sekundarne zloćudne bolesti
English: Ibritumomab tiuxetan targets the antigen CD20 which is located on the surface of malignant and normal B-lymphocytes.
Croatian: Ibritumomab tiuksetan cilja antigen CD20 koji se nalazi na površini zloćudnih i normalnih B-limfocita.
English: Taking into account the PRAC Assessment Report on the PSUR(s) for ibritumomab tiuxetan, the scientific conclusions of CHMP are as follows:
Croatian: Uzimajući u obzir PRAC-ovo izvješće o procjeni periodičkog(ih) izvješća o neškodljivosti lijeka (PSUR) za ibritumomab tiuksetan, znanstveni su zaključci CHMP-a sljedeći:
English: (AML)) *, **; tumour pain - fever with decrease in the number of specific white blood cells (febrile neutropenia);
Croatian: ,**, tumorska bol - vrućica sa smanjenjem broja specifičnih bijelih krvnih stanica (febrilna neutropenija),
English: • Human anti-murine antibodies
Croatian: • Humana antimišja protutijela
English: • extravasation (leakage of the infusion to the surrounding tissue): pain, burning sensation, stinging or another reaction at the infusion site during administration.
Croatian: • ekstravazacija (izlijevanje infuzije u okolno tkivo): bol, osjećaj pečenja, bockanje ili neka druga reakcija na mjestu infuzije tijekom primjene.
English: Limited data in elderly patients (aged ≥ 65 years) are available.
Croatian: Za bolesnike starije dobi (dobi ≥ 65 godina) dostupni su ograničeni podaci.
English: Zevalin must be used following pretreatment with rituximab for which breast-feeding is not recommended during treatment and up to 12 months following treatment (please refer to the Summary of Product Characteristics of rituximab for detailed guidance on its use).
Croatian: Zevalin se mora primjenjivati nakon prethodnog liječenja rituksimabom za koje se dojenje ne preporučuje tijekom te 12 mjeseci nakon liječenja (detaljne smjernice za primjenu rituksimaba potražite u Sažetku opisa svojstava lijeka za taj lijek).
English: Place ITLC strip in the developing chamber and allow the solvent front to migrate past the 5.4 cm mark.
Croatian: 3.) Postavite trakicu za ITLC u komoru za razvijanje pa pustite da fronta otapala prijeđe preko oznake od 5,4 m.
English: Add approximately 0.8 ml sodium chloride 9 mg/ml (0.9%) solution to developing chamber assuring the liquid will not touch the 1.4 cm origin mark on the ITCL strip.
Croatian: 1.) Dodajte približno 0,8 ml otopine natrijevog klorida od 9 mg/ml (0,9 %) u komoru za razvijanje pazeći da tekućina ne dodiruje oznaku početka od 1,4 cm na trakici za ITCL.
English: The final formulation after radiolabelling contains 2.08 mg ibritumomab tiuxetan [
Croatian: Konačna formulacija nakon radioaktivnog označavanja sadrži 2,08 mg ibritumomab tiuksetana [
English: Median TTP (Months) [Range
Croatian: Medijan DR-a (mjeseci) [raspon
English: Pregnancy must be excluded before the start of treatment in women.
Croatian: Prije početka liječenja u žena mora se isključiti mogućnost trudnoće.
English: Your doctor will perform tests to exclude pregnancy before you start the treatment.
Croatian: Prije početka liječenja liječnik će Vas testirati da bi isključio mogućnost trudnoće.
English: Adequate shielding is mandatory.
Croatian: Obavezna je odgovarajuća zaštitna oprema.
English: Haematological toxicity has been very commonly observed in clinical trials, and is dose-limiting (see also section ‘Special warnings and precautions for use').
Croatian: Hematološka toksičnost u kliničkim se ispitivanjima uočavala vrlo često te ograničava dozu (vidjeti također dio "Posebna upozorenja i mjere opreza pri uporabi").
English: The radioincorporation assay for radiochemical purity, is performed by Instant Thin Layer Chromatography (ITLC) and must be carried out according to the following procedure.
Croatian: Upute za određivanje postotka radioinkorporacije Test radioinkorporacije za radiokemijsku čistoću provodi se brzom tankoslojnom kromatografijom (ITLC-om), a valja ga provesti u skladu sa sljedećim postupkom.
English: In addition, Zevalin is not recommended for the use in patients with non-Hodgkin's lymphoma involving the brain and/or spinal cord as those patients were not included in clinical studies.
Croatian: Zevalin se, k tome, ne preporučuje za primjenu na bolesnicima s ne-Hodgkinovim limfomom koji je zahvatio mozak i/ili leđnu moždinu jer takvi bolesnici nisu bili uključeni u klinička ispitivanja.
English: Radiopharmaceuticals should be prepared in a manner which satisfies both radiation safety and pharmaceutical quality requirements.
Croatian: Radiofarmaceutike treba pripremati na način koji ispunjava i zahtjeve radiološke sigurnosti i zahtjeve farmaceutske kakvoće.
English: Spectrum Pharmaceuticals B.V. Prins Bernhardplein 200
Croatian: Prins Bernhardplein 200
English: In]-radiolabelled ibritumomab tiuxetan predicted acceptable radiation to normal human tissue with limited levels of skeleton and bone marrow radiation.
Croatian: In]-radioaktivno označenog ibritumomab tiuksetana na miševima predviđeno je prihvatljivo zračenje normalnog ljudskog tkiva s ograničenim razinama zračenja kostura i koštane srži.
English: Estimated Radiation Absorbed Doses From [
Croatian: Tablica 3: procijenjene apsorbirane doze zračenja od [
English: Preparation of Zevalin
Croatian: Priprema Zevalina
English: These reports originated either from clinical trials or from postmarking experience.
Croatian: Te prijave potječu iz kliničkih ispitivanja ili iz iskustava stečenih nakon stavljanja lijeka na tržište.
English: Y]-radiolabelled Zevalin at activities of 15 MBq/kg and 11 MBq/kg was calculated according to Medical Internal Radiation Dosimetry (MIRD) (Table 3).
Croatian: Y] pri djelovanju doza od 15 MBq/kg i 11 MBq/kg izračunata je na temelju medicinske interne dozimetrije zračenja (MIRD-a) (tablica 3).
English: The safety and efficacy of immunization with any vaccine, particularly live viral vaccines, following therapy with Zevalin have not been studied.
Croatian: Sigurnost i djelotvornost imunizacije, osobito cjepivom sa živim virusima, nakon terapije Zevalinom nisu ispitane.
English: Since Zevalin is used after pretreatment with rituximab (for details see section 4.2), see also the prescribing information of rituximab.
Croatian: Budući da se Zevalin primjenjuje nakon prethodnog liječenja rituksimabom (pojedinosti potražite u dijelu 4.2), pogledajte i podatke o propisivanju rituksimaba.
English: Signs and symptoms of infusion reactions may include dizziness, cough, nausea, vomiting, rash, pruritus, tachycardia, asthenia, pyrexia and rigors (see section 4.8).
Croatian: Znakovi i simptomi infuzijskih reakcija mogu obuhvaćati omaglicu, kašalj, mučninu, povraćanje, osip, svrbež, tahikardiju, asteniju, pireksiju i tresavicu (vidjeti dio 4.8).
English: Step 4: Add the formulation buffer to the reaction vial
Croatian: 4. korak: dodajte pufer za pripremu formulacije u bočicu za reakciju
English: Severe hypersensitivity reactions including anaphylaxis occur in < 1 % of patients (see also section 4.8).
Croatian: Jake reakcije preosjetljivosti, uključujući anafilaksiju, pojavljuju se u < 1 % bolesnika (vidjeti dio 4.8).
English: Animal reproduction studies were not conducted with ibritumomab tiuxetan.
Croatian: Nisu provedena ispitivanja reprodukcije na životinjama s ibritumomab tiuksetanom.
English: Sterility
Croatian: Sterilnost
English: Although it is not known whether ibritumomab tiuxetan is excreted in human milk, maternal IgGs are known to be excreted in human milk.
Croatian: Iako nije poznato izlučuje li se ibritumomab tiuksetan u majčino mlijeko u ljudi, poznato je da se u majčino mlijeko izlučuju majčina IgG protutijela.
English: Do not use Zevalin after the expiry date which is stated on the pack.
Croatian: Zevalin se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na pakiranju.
English: In a secondary analysis comparing objective response to the Zevalin therapeutic regimen with that observed with the most recent treatment with rituximab, the median duration of response following the Zevalin therapeutic regimen was 6 vs. 4 months.
Croatian: U sekundarnoj analizi kojom su uspoređeni objektivni odgovor na liječenje Zevalinom s odgovorom na zadnje liječenje rituksimabom, medijan trajanja odgovora bio je 6 nasuprot 4 mjeseca.
English: The single and repeated dose toxicity studies of the non-radioactive compound in cynomolgus monkeys did not indicate any other risk than the expected B-cell depletion arising from the use of ibritumomab tiuxetan alone or in combination with rituximab.
Croatian: Ispitivanja toksičnosti pojedinačne i ponovljenih doza neradioaktivnog spoja u makaki majmunima ne pokazuju nikakve druge rizike osim očekivane deplecije broja B-stanica prouzročene ibritumomab tiuksetanom primijenjenog samostalno ili u kombinaciji s rituksimabom.
English: - Developing chamber for chromatography - Mobile phase: sodium chloride 9 mg/ml (0.9%) solution, bacteriostatic-free - ITLC strips (e.g. ITLC TEC-Control Chromatography Strips, Biodex, Shirley, New York, USA, Art. Nr. 150-772 or equivalent, dimensions: approximately 0.5-1 cm x 6 cm) - Scintillation vials - Liquid scintillation cocktail (e.g. Ultima Gold, catalog No. 6013329, Packard Instruments, USA or equivalent)
Croatian: - komora za razvijanje za kromatografiju - mobilna faza: otopina natrijevog klorida od 9 mg/ml (0,9 %), bez bakteriostatika - trakice za ITLC (npr. TEC-kontrolne kromatrografske trakice za ITLC koje proizvodi Biodex, Shirley, New York, SAD, šifra proizvoda 150-772, odnosno ekvivalentne, dimenzija: približno 0,5-1 cm x 6 cm) - bočice za scintilaciju - tekući scintilacijski koktel (primjerice, Ultima Gold, kataloški br. 6013329, koji proizvodi Packard Instruments, SAD, ili ekvivalentan)